Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation

被引:8
|
作者
Najafi, Maryam [1 ]
Kordi-Tamandani, Dor Mohammad [1 ]
Arish, Mohammad [2 ]
机构
[1] Univ Sistan & Baluchestan, Dept Biol, Zahedan, Iran
[2] Zahedan Univ Med Sci, Dept Ophthalmol, Al Zahra Eye Hosp, Zahedan 9816743463, Iran
关键词
TUMOR-SUPPRESSOR GENES; DOWN-REGULATION; HYPERMETHYLATION; ASSOCIATION; EXPRESSION; IRRADIATION; PATHWAY; GROWTH;
D O I
10.1155/2016/5431021
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Pterygium is a serious eye problem in countries with high exposure to UV. However, despite numerous studies, the molecular etiology of pterygium is unclear. Recent studies have indicated that LATS1 and LATS2 genes are involved in DDR signaling pathways against continuous UV exposure. Our aim was to evaluate the LATS1 and LATS2 promoter methylation with the risk of pterygium formation. Methods. We evaluated the promoter methylation status of LATS1 and LATS2 using methylation-specific PCR technique. Also, mRNAexpression of LATS1 and LATS2 was assessed in 14 cases of pterygium and 14 normal specimens by real-time PCR. Results. Promoter methylation of LATS1 and LATS2 was detected significantly between pterygium tissues and normal tissues [LATS1; OR = 4.9; 95% CI: 1.54 to 15.48, P = 0.003; LATS2; OR = 7.1; 95% CI: 1.53 to 33.19, P = 0.004]. The gene expression analysis showed a statistically significant difference between pterygium tissues and healthy controls for both LATS1 and LATS2 (P < 0.05). Conclusions. The data of this study is the first report regarding the effect of promoter methylation of the LATS1 and LATS2 in the pterygium. To confirm these data, doing further studies in various genetic populations with large sample sizes using advanced molecular techniques is proposed.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Promoter hypermethylation-mediated down-regulation of LATS 1 and LATS2 in human astrocytoma
    Jiang, Zheng
    Li, Xingang
    Hu, Jin
    Zhou, Wei
    Jiang, Yuquan
    Li, Gang
    Lu, Daru
    NEUROSCIENCE RESEARCH, 2006, 56 (04) : 450 - 458
  • [22] Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers
    Takahashi, Y
    Miyoshi, Y
    Takahata, C
    Irahara, N
    Taguchi, T
    Tamaki, Y
    Noguchi, S
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1380 - 1385
  • [23] Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate
    Menard, Amelie
    Abou Nader, Nour
    Levasseur, Adrien
    St-Jean, Guillaume
    Le Gad-Le Roy, Marie
    Boerboom, Derek
    Benoit-Biancamano, Marie-Odile
    Boyer, Alexandre
    ENDOCRINOLOGY, 2020, 161 (06)
  • [24] The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1
    Han Han
    Hiroki J. Nakaoka
    Line Hofmann
    Jeff Jiajing Zhou
    Clinton Yu
    Lisha Zeng
    Junyu Nan
    Gayoung Seo
    Rebecca Elizabeth Vargas
    Bing Yang
    Ruxi Qi
    Lee Bardwell
    Dmitry A. Fishman
    Ken W. Y. Cho
    Lan Huang
    Ray Luo
    Rahul Warrior
    Wenqi Wang
    Nature Cell Biology, 2022, 24 : 74 - 87
  • [25] LATS1 and LATS2 Phosphorylate CDC26 to Modulate Assembly of the Tetratricopeptide Repeat Subcomplex of APC/C
    Masuda, Kenta
    Chiyoda, Tatsuyuki
    Sugiyama, Naoyuki
    Segura-Cabrera, Aldo
    Kabe, Yasuaki
    Ueki, Arisa
    Banno, Koji
    Suematsu, Makoto
    Aoki, Daisuke
    Ishihama, Yasushi
    Saya, Hideyuki
    Kuninaka, Shinji
    PLOS ONE, 2015, 10 (02):
  • [26] Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma
    Malik, Showkat A.
    Khan, Mosin S.
    Dar, Majeed
    Ul Hussain, Mahboob
    Shah, Mohammad A.
    Shafi, Sheikh M.
    Mudassar, Syed
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (02) : 207 - 214
  • [27] An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
    Park, Gun-Soo
    Oh, Hyangyee
    Kim, Minchul
    Kim, Tackhoon
    Johnson, Randy L.
    Irvine, Kenneth D.
    Lim, Dae-Sik
    ONCOTARGET, 2016, 7 (17) : 24063 - 24075
  • [28] Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer
    Yu, Tian
    Bachman, John
    Lai, Zhi-Chun
    PROTEIN & CELL, 2015, 6 (01) : 6 - 11
  • [29] The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1
    Han, Han
    Nakaoka, Hiroki J.
    Hofmann, Line
    Zhou, Jeff Jiajing
    Yu, Clinton
    Zeng, Lisha
    Nan, Junyu
    Seo, Gayoung
    Vargas, Rebecca Elizabeth
    Yang, Bing
    Qi, Ruxi
    Bardwell, Lee
    Fishman, Dmitry A.
    Cho, Ken W. Y.
    Huang, Lan
    Luo, Ray
    Warrior, Rahul
    Wang, Wenqi
    NATURE CELL BIOLOGY, 2022, 24 (01) : 74 - +
  • [30] Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis
    Mohad, Vidisha
    Lungova, Vlasta
    Verheyden, Jamie
    Thibeault, Susan L.
    DEVELOPMENTAL BIOLOGY, 2021, 473 : 33 - 49